Fe3O4/anti-IgG/GQD/BSA |
Coupling |
Human IgG |
Urine renal disease |
[83] |
Ab (anti-aflatoxin B1)–CdS–Fe3O4 bioconjugates |
Coupling |
Aflatoxin B1 |
Detection of aflatoxin B1 B1 in corn samples |
[84] |
Dox-loaded carbon dot (CD)–4-carboxyphenylboronic acid (CBBA)–MnFe2O4 NPs [DCCM] |
Coupling |
Sialic acid |
HeLa cells |
[85] |
Iron oxide superparamagnetic NPs-PEG-Cypher5E/folic acid |
Coupling |
Folic acid |
MR imaging and fluorescence imaging |
[86] |
Fe3O4(MNP)-Cds(QDs)-folic acid |
Coupling |
Folic acid |
As a delivery agent and an in vitro imaging diagnostic agent |
[87] |
MTX-PEG-CS-IONPs-Cy5.5 |
Coupling |
Folic acid |
Dual-model imaging and synergistically self-targeted cancer therapy |
[88] |
Fe3O4-dopamine hydrobromide (DPA)-PEG-FA/FITC NPs |
Coupling |
Folic acid |
Targeted imaging of various tumors |
[89] |
Fe3O4-CdTe-humanized monoclonal antibody CC49 (hCC49 antibody) |
Coupling |
Tumor-associated glycoprotein-72 (TAG-72) |
Cancer cell imaging |
[90] |
Fe3O4@mSiO2–triphenylphospine (TPP)/CD |
Coupling |
Mitochondria |
Mitochondrial diseases |
[91] |
BRCAA1 antibody-FMNPs (Fe3O4-CdTe) |
Encapsulation |
BRCAA1 protein |
In vivo dual-model imaging of gastric cancer |
[92] |
FMN (flavin mononucleotide)-coated ultrasmall superparamagnetic iron oxide (FLUSPIO) |
Encapsulation |
Riboflavin (Rf) |
Prostate cancer xenografts |
[93] |
MNPs@OPE[oligo(p-phenylene ethynylene)]-PEG-FA |
|
Folate receptor |
Targeted magnetic resonance and two-photon optical imaging in vitro and in vivo |
[94] |
Fe3O4@SiO2/RhBITC-anti-HER2 antibody NPs |
Encapsulation |
Human epidermal growth factor receptor 2 (HER2) |
Discrimination of HER2-positive breast cancer cells |
[95] |
Fe3O4@SiO2(FITC)-FA/AICAR(5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside)/DOX |
Encapsulation |
Folate receptor |
Inhibition of cancer cell growth |
[96] |
PTX/Fe3O4 NPs/CuInS2/ZnS QDs@biotin–PEG–PCD [abiotin–poly(ethylene glycol)–poly (curcumin-dithiodipropionic acid) copolymer] |
Encapsulation |
Biotin receptor |
Treatment of multidrug-resistant breast cancer at the cellular level |
[97] |
Trastuzumab-conjugated Lipo[MNP@m-SiO2(FITC)] |
Encapsulation |
Her2/neu |
In vitro fluorescence and MR imaging of Her2/neu-positive breast cancer |
[98] |
Fe3O4/CuInS2(CIS)@SiO2(Gd–DTPA)–RGD (arginine-glycine-aspartic acid) |
Encapsulation |
αVβ3 integrin |
MR and fluorescence imaging of pancreatic cancer |
[99] |